Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crown Bioscience is an industry-leading global contract research organization specializing in preclinical and translational services for oncology and immuno-oncology drug discovery. They offer the world’s largest commercial collection of patient-derived xenograft (PDX) models and over 600 tumor organoid models using Hubrecht Organoid Technology. Their expertise spans in vivo, in vitro, ex vivo, and in silico methods to accelerate drug development timelines for biopharma clients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crown Scientific.